David M. Lough

Health Technology

Consumer Services

Profile

David M.
Lough worked as a Director of Business Development at Idera Pharmaceuticals, Inc. and as a Manager of East Coast Operations at Sequenom, Inc. He received an undergraduate degree and a doctorate from The University of Edinburgh in 1993 and 1996 respectively, and an undergraduate degree from Northeastern University in 2004.

Former positions of David M. Lough

Companies	Position	End
SEQUENOM, INC.	Corporate Officer/Principal	-
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Corporate Officer/Principal	-

See the detail of David M. Lough's experience

Training of David M. Lough

The University of Edinburgh	Doctorate Degree
Northeastern University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David M. Lough's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.	Health Technology
Sequenom, Inc. Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC.	Health Technology